BTC/USD
$ 63,437  -0.49%
BTC/EUR
€ 59,366  -0.48%
BTC/CNY
¥ 172,521  0%
BTC/GBP
£ 50,200  -1.68%
BTC/RUB
₽ 3,900,027  0%
BTC volume
$ 6.10B
Altcoin volume
$ 22.84B
Crypto market cap
$ 2.11T
    Dernier prix % 24 Haute 24 Faible 24 Volume # Pièces de monnaie Capitalisation boursière

Medicalveda

MVEDA

$ 0.002422 0 % $ 0.002422 $ 0.002422
Medicalveda

Medicalveda MVEDA

Dernier prix
$ 0.002422
%
0 %
24 Haute
$ 0.002422
24 Faible
$ 0.002422
24 Volume
# Pièces de monnaie
Capitalisation boursière
Medicalveda Graphiques
Medicalveda Les marchés
Bourse Paire Dernier prix 24 Volume
Exmarkets MVEDA/ETH $ 0.006957   $ 0.00
Classement cryptomonnaie: #5695 
Algorithme: 
Mineable:No 
Token de plateforme:Ethereum 
maximum historique:$ 0.11799806 
Stock maximal:88,000,000 
Minimum historique:$ 0.00203144 
Circulating supply: 
ICO Prix: n/a 
Cointype:utility token 
Minimum historique:$ 0.00203144 
Circulating supply: 
ICO ROI:n/a 
Date de sortie:  
Medicalveda Flux de médias sociaux
Latest News
28. Apr 2024 | Guest 27. Apr 2024 | Bakshi A.
BDAG 4-Month Vesting Period News Outshines XRP Whales & Tron Shiba Inu Prepares for Shibarium Hard Fork: A Game-Changer in Cryptocurrency Evolution
27. Apr 2024 | Guest 27. Apr 2024 | Guest
Best Crypto Presales: BlockDAG Tops the List Against DOGEVERSE, SLOTH & 5SCAPE Buy BDAG with USDT & Low ETH fees; Easy ERC-20 Transfers
26. Apr 2024 | Laurent C. 26. Apr 2024 | Laurent C.
Bitcoin Developer's Critique Sparks Debate Over Runes Protocol The recent stagnation in Bitcoin ETF inflows reflects a cooling trend in the cryptocurrency market
26. Apr 2024 | Guest 26. Apr 2024 | Bailey S.
Discover BlockDAG's 2024 Breakthrough with a $20.7M Presale and Moon-Shot Keynote FBI Warns of Consequences for Non-Compliant Crypto Services in Evolving Regulatory Landscape

We will update this as soon as possible. If you like to help, you can contact us.

 
We use cookies for analytics, advertising and to improve our site. To find out more about our cookies, see our Privacy Policy. If you agree to our use of cookies, please continue to use our site or press the accept button. Learn more